Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

Mise à jour : Il y a 4 ans
Référence : NCT02065882

Femme et Homme

Extrait

The purpose of the study is to investigate pharmacokinetics, efficacy and safety of BT524 in patients with congenital fibrinogen deficiency.


Critère d'inclusion

  • Congenital afibrinogenemia ,Congenital Hypofibrinogenemia


Liens